Skip to main content

Mustafa Shadi Rifaat Bashir

Professor of Radiology
Radiology, Abdominal Imaging
Dept of Radiology, Box 3808, Durham, NC 27710

Overview


Hepatobiliary and pancreatic imaging
Liver cancer (hepatocellular carcinoma)
Fatty liver, NAFLD, and NASH
Chronic liver disease and cirrhosis
Pancreatic cancer
Technical development in MRI
Quantitative imaging

Current Appointments & Affiliations


Professor of Radiology · 2022 - Present Radiology, Abdominal Imaging, Radiology
Professor in Medicine · 2022 - Present Medicine, Gastroenterology, Medicine
Member of the Duke Cancer Institute · 2016 - Present Duke Cancer Institute, Institutes and Centers

Recent Publications


Performing liver imaging at a high level: quality and adequacy in LI-RADS.

Journal Article Abdom Radiol (NY) · June 2025 Imaging is critical to HCC management, including surveillance, diagnosis, staging, and treatment response assessment, which requires it be performed consistently at a high level. The Liver Imaging Reporting and Data System (LI-RADS) was developed to standa ... Full text Link to item Cite

MRI-based prediction of microvascular invasion/high tumor grade and adjuvant therapy benefit for solitary HCC ≤ 5 cm: a multicenter cohort study.

Journal Article Eur Radiol · June 2025 OBJECTIVES: To develop and externally validate an MRI-based diagnostic model for microvascular invasion (MVI) or Edmondson-Steiner G3/4 (i.e., high-risk histopathology) in solitary BCLC 0/A hepatocellular carcinoma (HCC) ≤ 5 cm and to assess its performanc ... Full text Link to item Cite

Large Language Models for Diagnosing Focal Liver Lesions From CT/MRI Reports: A Comparative Study With Radiologists.

Journal Article Liver Int · June 2025 BACKGROUND & AIMS: Whether large language models (LLMs) could be integrated into the diagnostic workflow of focal liver lesions (FLLs) remains unclear. We aimed to investigate two generic LLMs (ChatGPT-4o and Gemini) regarding their diagnostic accuracies r ... Full text Link to item Cite
View All Publications

Recent Grants


Evaluation of Efficacy, Safety and Tolerability of NGM282-PS-231 - NGM08

Clinical TrialPrincipal Investigator · Awarded by NGM Biopharmaceuticals, Inc. · 2024 - 2031

Genomic Imprinting in the Development of NAFLD

ResearchCollaborator · Awarded by National Institute of Diabetes and Digestive and Kidney Diseases · 2024 - 2028

View All Grants

Education, Training & Certifications


University of Iowa · 2004 M.D.